Abstract
Thiazide diuretics are widely used to treat hypertension, but their use is associated with impaired glucose tolerance. We propose that the diabetogenic action of thiazides may be due to their ability to open calcium-activated potassium (KCa) channels in pancreatic beta-cells.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Benzothiadiazines*
-
Calcium Channels / drug effects*
-
Calcium Channels / metabolism
-
Carbonic Anhydrase Inhibitors / pharmacology
-
Carbonic Anhydrases / drug effects*
-
Carbonic Anhydrases / metabolism
-
Diuretics
-
Humans
-
Hyperglycemia / chemically induced*
-
Hyperglycemia / etiology
-
Hypertension / drug therapy
-
Islets of Langerhans / drug effects*
-
Islets of Langerhans / metabolism
-
Potassium Channels / drug effects*
-
Potassium Channels / metabolism
-
Sodium Chloride Symporter Inhibitors / adverse effects*
-
Sodium Chloride Symporter Inhibitors / therapeutic use
Substances
-
Benzothiadiazines
-
Calcium Channels
-
Carbonic Anhydrase Inhibitors
-
Diuretics
-
Potassium Channels
-
Sodium Chloride Symporter Inhibitors
-
Carbonic Anhydrases